Cell and Gene Therapy Clinical Trials Market By Therapy Type (Cell Therapy {Autologous Cell Therapy, Allogeneic Cell Therapy, CAR-T Cell Therapy, Natural Killer Cell Therapy, Dendritic Cell Therapy, Stem Cell Therapy}, Gene Therapy {In-vivo Gene Therapy, Ex-vivo Gene Therapy}), By Phase (Phase I, Phase II, Phase III, Phase IV), By Disease Type (Oncology, Genetic Disorders, Neurological Disorders, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Others), By Trial Sponsor (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Government and Non-Profit Organizations, Contract Research Organizations), By Gene Therapy Type (Viral Vector-based Gene Therapy {Adeno-associated Virus, Lentivirus, Retrovirus, Adenovirus}, Non-viral Vector-based Gene Therapy, Others), By Route of Administration (Intravenous, Intramuscular, Intrathecal, Intraocular, Subcutaneous, Others), and By End-User (Hospitals and Clinics, Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035.

---

Report Coverage:

By Therapy Type

• Cell Therapy
  • Autologous Cell Therapy
  • Allogeneic Cell Therapy
  • CAR-T Cell Therapy
  • Natural Killer Cell Therapy
  • Dendritic Cell Therapy
  • Stem Cell Therapy
• Gene Therapy
  • In vivo Gene Therapy
  • Ex vivo Gene Therapy

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Disease Type

• Oncology
• Genetic Disorders
• Neurological Disorders
• Cardiovascular Diseases
• Autoimmune Diseases
• Infectious Diseases
• Others

By Trial Sponsor

• Pharmaceutical Companies
• Biotechnology Companies
• Academic and Research Institutions
• Government and Non-Profit Organizations
• Contract Research Organizations

By Gene Therapy Type

• Viral Vector-based Gene Therapy
  • Adeno-associated Virus
  • Lentivirus
  • Retrovirus
  • Adenovirus
• Non-viral Vector-based Gene Therapy
• Others

By Route of Administration

• Intravenous
• Intramuscular
• Intrathecal
• Intraocular
• Subcutaneous
• Others

By End-User

• Hospitals and Clinics
• Academic and Research Institutes
• Biopharmaceutical Companies
• Contract Research Organizations
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Switzerland
• Sweden
• Finland
• Netherland
• Poland
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Indonesia
• Malaysia
• Philippines
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• CRISPR Therapeutics AG
• Vertex Pharmaceuticals Incorporated
• Gilead Sciences, Inc.
• Novartis AG
• bluebird bio, Inc.
• Sarepta Therapeutics, Inc.
• Spark Therapeutics, Inc.
• Editas Medicine, Inc.
• Intellia Therapeutics, Inc.
• Sana Biotechnology, Inc.
• Beam Therapeutics Inc.
• Verve Therapeutics, Inc.
• Precision BioSciences, Inc.
• Adaptimmune Therapeutics plc
• Regenxbio Inc.